The first steps towards developing a vaccine against an insidious sexual transmitted infection (STI) have been accomplished by researchers at McMaster University.
Researchers at the Michael G. DeGroote Institute for Infectious Disease Research at McMaster have developed the first widely protective vaccine against chlamydia, a common STI that is mostly asymptomatic but impacts 113 million people around the world each year and can result in infertility.
In a study, recently published in the journal Vaccine, the researchers show that a novel chlamydial antigen known as BD584 is a potential vaccine candidate for the most common species of chlamydia known as Chlamydia trachomatis.
As most C. trachomatis infections are asymptomatic, chlamydia can often go untreated and lead to upper genital tract infections, pelvic inflammatory disease, and infertility. This is why the promise of a vaccine would be extremely beneficial, says David Bulir, co-author of the study.
“Vaccine development efforts in the past three decades have been unproductive and there is no vaccine approved for use in humans,” said Bulir, who just finished his PhD in medical sciences at McMaster.
“Vaccination would be the best way to way to prevent a chlamydia infection, and this study has identified important new antigens which could be used as part of a vaccine to prevent or eliminate the damaging reproductive consequences of untreated infections.”
In the research team’s study, BD584 was able to reduce chlamydial shedding – a symptom of C. trachomatis – by 95 per cent. The antigen also decreased hydrosalpinx, another C. trachomatis symptom which involves fallopian tubes being blocked with serous fluids, by 87.5 per cent.
The results look very promising, said senior author James Mahony, a professor of Pathology and Molecular Medicine for McMaster’s Michael G. DeGroote School of Medicine and a researcher at St. Joseph Healthcare Hamilton’s Research Institute where the work was performed.
Co-author and McMaster PhD student, Steven Liang, explains, “not only is the vaccine effective, it also has the potential to be widely protective against all C. trachomatis strains, including those that cause trachoma.”
Trachoma is an eye infection caused by chlamydia and is the leading cause of preventable blindness affecting millions of people in many resource-poor regions of the world.
“The vaccine would be administered through the nose. This is easy and painless and does not require highly trained health professionals to administer, and that makes it an inexpensive solution for developing nations,” he said.
The next step is more testing for effectiveness against different strains of Chlamydia and in different formulations. The study was funded by the Canadian Institutes for Health Research.
The Latest on: Chlamydia
via Google News
The Latest on: Chlamydia
- Kansas sees rise in STD cases, especially in rural countieson September 13, 2019 at 5:06 pm
There's drug abuse, sex trafficking, gaps in sex education classes for teens and a laundry list of cultural taboos all leading to an environment where gonorrhea, syphilis, chlamydia and, now, HIV ...
- Utah county saw more chlamydia diagnoses than flu cases last yearon September 11, 2019 at 11:58 am
Sexually transmitted diseases increased in Utah County for the fifth year in a row, according to the Daily Herald. Between 2011 and 2017, the average annual case count for chlamydia was 999 cases.
- More chlamydia cases than the flu last year in Utah Countyon September 9, 2019 at 8:30 am
PROVO, Utah (AP) — Utah County health officials say sexually transmitted diseases continue to rise in the region for at least the fifth year in a row. The Provo Daily Herald reports officials say each ...
- More people were diagnosed with chlamydia than the flu last year in Utah Countyon September 8, 2019 at 9:00 am
Sexually transmitted diseases continue to rise for at least the fifth year in a row, according to information from the Utah County Health Department. Each of the four major STDs tracked by the health ...
- Chlamydia increases risk for PID, ectopic pregnancy, female infertilityon September 5, 2019 at 8:35 am
Results from a large retrospective study confirmed an association between Chlamydia trachomatis and an increased risk for pelvic inflammatory disease, ectopic pregnancy and female infertility, ...
- Chlamydia Infection Market Growth Focusing on Major Key Players: Abbott Laboratories, BioMerieux and Danaher Corporationon August 30, 2019 at 12:36 am
Aug 30, 2019 (WiredRelease via COMTEX) -- The key contributing factors chlamydia infection market are increasing Sales Strategy, Revenue Generation, Valuable Growth Prospects, and Cost Structure ...
- Southern Charm: Danni Baird cries during final reunion show over chlamydia rumor by Madison LeCroyon August 28, 2019 at 8:57 pm
Madison LeCroy made peace with Danni Baird on Wednesday's final Southern Charm reunion on Bravo after making her cry by spreading a chlamydia rumor . The 32-year-old hair stylist also talked about her ...
- New rapid DNA test to diagnose chlamydia infection in koalason August 21, 2019 at 12:31 am
A new DNA test to detect chlamydia infection in koalas which can be run in the field and gives on-the-spot results within 30 minutes has been developed in a research collaboration between researchers ...
- How Does The Vagina Protect Itself From Chlamydia?on August 20, 2019 at 6:00 pm
Resilience against chlamydia, the most widespread sexually transmitted infection (STI) in America, is dependant upon the properties of the microbes present in the vagina and cervix. A study published ...
- Chlamydia Vaccine Clears Early Hurdle in Human Trialson August 16, 2019 at 12:46 pm
A new vaccine that might prevent the spread of chlamydia, the most common bacterial sexually transmitted disease in the world, was shown to be safe and effective in a phase 1 trial. The findings, ...
via Bing News